<DOC>
	<DOCNO>NCT00575614</DOCNO>
	<brief_summary>The purpose study determine whether prucalopride safe effective treatment chronic idiopathic constipation . Hypothesis : Prucalopride give dose 1 mg o.d . 4 week female patient chronic constipation show favourable effect efficacy parameter assess trial . This dosage consider safe generally well-tolerated .</brief_summary>
	<brief_title>Prucalopride Patients With Chronic Idiopathic Constipation</brief_title>
	<detailed_description>This randomize , double-blind , placebo-controlled , parallel-group , phase II trial set investigate efficacy , safety physiological effect prucalopride 1 mg administer o.d . 4 week female patient chronic idiopathic constipation . The primary objective trial ass effect prucalopride 1 mg whole gut transit ( measure change baseline total number marker ) .</detailed_description>
	<mesh_term>Constipation</mesh_term>
	<criteria>female subject 18 year ; history chronic constipation least 6 month selection , characterize either two few spontaneous ( ie , without use laxative ) bowel movement week strain defaecation least quarter time ; write informed consent ; within 20 % body weight specify Metropolitan Life Insurance Company 's 1983 Height Weight Table2 ; healthy basis pretrial physical examination , medical history , anamnesis , electrocardiogram result biochemistry , haematology urinalysis , carry within 3 week randomization . If result laboratory test within reference range , subject could include condition investigator judge deviation clinically relevant . use disallow concomitant medication ; subject undergone surgery constipation ; subject faecal impaction ; subject suffer different type cause constipation idiopathic constipation , ie , presence secondary cause , eg , endocrine disorder , metabolic disorder , neurologic disorder ; subject megacolon/megarectum ; subject external rectal prolapse ; history previous abdominal surgery ( hysterectomy , surgery Meckel 's diverticle , appendectomy , cholecystectomy , inguinal hernia repair , splenectomy , nephrectomy fundoplication ) think primary cause constipation ; know suspect organic disorder large bowel , ie , obstruction , carcinoma inflammatory bowel disease . If complaint constipation recent onset , ie , present less one year , subject 40 year old , result Baenema colonoscopic examination require ; subject solitary rectal ulcer ( excluded rigid sigmoidoscopic examination first visit ) ; subject active proctological condition think responsible constipation ; subject know illness condition : severe cardiovascular lung disease , neurologic psychiatric disorder ( include substance abuse/dependence , exception nicotine ) , alcoholism , cancer AIDS gastrointestinal endocrine disorder ; subject receive , receive , care eat disorder ; subject impair renal function ; subject serum amylase , serum glutamicoxaloacetic transaminase ( SGOT ) , serum glutamicpyruvic transaminase ( SGPT ) concentration &gt; 2 time normal limit ; pregnancy wish become pregnant course trial . Lack acceptable birth control method ; breastfeeding ; subject receive investigational drug 30 day precede trial ; subject unable unwilling return require followup visit ; subject whose reliability physical state would prevent proper evaluation drug trial ; history suspicion alcohol drug abuse .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Constipation</keyword>
	<keyword>Prucalopride</keyword>
	<keyword>Ano-rectal physiology</keyword>
	<keyword>Oro-caecal transit time</keyword>
	<keyword>QOL</keyword>
</DOC>